Keywords
testosterone
estrogen
prolactin
vitamin D
Abstract
Aim. Vitamin D is currently an exciting research target, besides its obvious role in calcium homeostasis and bone health, enormous work is being directed at examining the effects of this vitamin on various biological functions and pathological conditions.
Material and methods. The review of the literature and the analysis took about six months and was carried out through PubMed. This is a search engine opening mainly the MEDLINE database of trusted references. We called up all studies written in English that were published between the years 2004 to 2021 and that came through using the applied search terms, and analysed all those that met the criteria.
Results. The endocrine system with its many glands and hormones and their essential roles in the maintenance of normal body functioning cannot be far from interactions with vitamin D. Male and female sex hormones are no exceptions and many studies have investigated the correlations between these hormones and vitamin D. As such, direct and indirect relationships have been found between vitamin D, its receptors or one of its metabolising enzymes with sex hormones and the development of reproductive organs in males and females.
Conclusion. This review summarises the research investigating the associations of vitamin D with sex hormones and reproductive organs in males and females, and thus may pave the road for future studies that will investigate the clinical significance of vitamin D in the management of reproductive system disorders. Despite some conflicting results about the relationship between VD and the effectiveness of the reproductive system, many studies confirm the presence of receptors for this vitamin in the reproductive system, and this supports the direct or indirect relationship between VD and prolactin or VD and testosterone through PO4 and Ca2+ homeostasis, or production of osteocalcin. Therefore, VD is positively associated with semen quality and androgen status. Furthermore, a direct relationship between VD and the production of progesterone, estrogen and estrone in human ovarian cells has been supported by many studies.
References
1. Boisen IM, Bøllehuus Hansen L, Mortensen LJ, Lanske B, Juul A, Blomberg Jensen M. Possible influence of vitamin D on male reproduction. J Steroid Biochem Mol Biol. 2017;173:215-22.
2. Jones G, Prosser DE, Kaufmann M. 25-Hydroxyvitamin D-24-hydroxylase (CYP24A1): Its important role in the degradation of vitamin D. Arch Biochem Biophys. 2012;523(1):9-18.
3. Bouillon R, Carmeliet G, Verlinden L, Van Etten E, Verstuyf A, Luderer HF, et al. Vitamin D and human health: Lessons from vitamin D receptor null mice. Endocr Rev. 2008;29(6):726-76.
4. Alnori H, Alassaf FA, Alfahad M, Qazzaz ME, Jasim M, Abed MN. Vitamin D and immunoglobulin E status in allergic rhinitis patients compared to healthy people. J Med Life. 2020;13(4):463-8.
5. Prosser DE, Jones G. Enzymes involved in the activation and inactivation of vitamin D. Trends Biochem Sci. 2004;29(12):664-73.
6. Hoenderop JGJ, Bindels RJM. Is vitamin D indispensable for Ca2+ homeostasis: Lessons from knockout mouse models? Nephrol Dial Transplant. 2005;20(5):864-7.
7. Ji H-F, Shen L. CYP24A1 mutations in idiopathic infantile hypercalcemia. N Engl J Med. 2011;365(18):1741-3.
8. Mawhinney M, Mariotti A. Physiology, pathology and pharmacology of the male reproductive system. Periodontol 2000. 2013;61(1):232-51.
9. Jensen MB. Vitamin D and male reproduction. Nat Rev Endocrinol. 2014;10(3):175-86.
10. Cornwall GA. New insights into epididymal biology and function. Hum Reprod Update. 2009;15(2):213-27.
11. Foster RA. Male Reproductive System. Elsevier Public Health Emergency Collection. 2016;3:465-510.
12. O’Donnell L, Meachem SJ, Stanton PG, McLachlan RI. Endocrine regulation of spermatogenesis. In: Knobil and Neill’s physiology of reproduction. Cambridge: Academic Press; 2006:1017-69.
13. O’Shaughnessy PJ, Monteiro A, Verhoeven G, De Gendt K, Abel MH. Effect of FSH on testicular morphology and spermatogenesis in gonadotrophin-deficient hypogonadal mice lacking androgen receptors. Reproduction. 2010;139(1):177-84.
14. Bolland MJ, Grey A, Horne AM, Reid IR. Testosterone levels following decreases in serum osteocalcin. Calcif Tissue Int. 2013;93(2):133-6.
15. Mortimer D, Barratt CLR, Björndahl L, de Jager C, Jequier AM, Muller CH. What should it take to describe a substance or product as “sperm-safe”. Hum Reprod Update. 2013;19(Suppl 1):145.
16. Yaghjyan L, Colditz GA, Drake B. Vitamin D and mammographic breast density: A systematic review. Cancer Causes Control. 2012;23(1):1-13.
17. Verstuyf A, Carmeliet G, Bouillon R, Mathieu C. Vitamin D: A pleiotropic hormone. Kidney Int. 2010;78(2):140-5.
18. Blomberg Jensen M, Nielsen JE, Jørgensen A, Rajpert-De Meyts E, Kristensen DM, Jørgensen N, et al. Vitamin D receptor and vitamin D metabolizing enzymes are expressed in the human male reproductive tract. Hum Reprod. 2010;25(5):1303-11.
19. Aquila S, Guido C, Middea E, Perrotta I, Bruno R, Pellegrino M, et al. Human male gamete endocrinology: 1alpha, 25-dihydroxyvitamin D3 (1,25(OH)2D3) regulates different aspects of human sperm biology and metabolism. Reprod Biol Endocrinol. 2009;7(1):140.
20. Niederberger C. Re: Are serum levels of vitamin d associated with semen quality? Results from a cross-sectional study in young healthy men. J Urol. 2012;187(1):240-1.
21. Blomberg Jensen M, Lieben L, Nielsen JE, Willems A, Jørgensen A, Juul A, et al. Characterization of the testicular, epididymal and endocrine phenotypes in the Leuven Vdr-deficient mouse model: Targeting estrogen signalling. Mol Cell Endocrinol. 2013;377(1-2): 93-102.
22. Rosol TJ, Gröne A. Endocrine Glands. Jubb, Kennedy Palmer’s Pathol Domest Anim. 2016;3:269-357.
23. Malloy PJ, Tiosano D, Feldman D. Hereditary 1, 25-dihydroxyvita-min-D-resistant rickets with alopecia resulting from a novel missense mutation in the DNA-binding domain of the vitamin D receptor. Mol Genet Metab. 2010;99(1)72-9.
24. Hammoud AO, Wayne Meikle A, Matthew Peterson C, Stanford J, Gibson M, Carrell DT. Association of 25-hydroxy-vitamin D levels with semen and hormonal parameters. Asian J Androl. 2012; 14(6):855-9.
25. Lerchbaum E, Pilz S, Trummer C, Schwetz V, Pachernegg O, Heijboer AC, et al. Vitamin D and testosterone in healthy men: A randomized controlled trial. J Clin Endocrinol Metab. 2017;102(11):4292-302.
26. Lerchbaum E, Trummer C, Theiler-Schwetz V, Kollmann M, Wölfler M, Heijboer AC, et al. Effects of vitamin D supplementation on androgens in men with low testosterone levels: A randomized controlled trial. Eur J Nutr. 2019;58(8):3135-46.
27. Wehr E, Pilz S, Boehm BO, März W, Obermayer-Pietsch B. Association of vitamin D status with serum androgen levels in men. Clin Endocrinol (Oxf). 2010;73(2):243-8.
28. Seftel A. Effect of vitamin D supplementation on testosterone levels in men: Editorial comment. J Urol. 2011;186(1):239-40.
29. Anic GM, Albanes D, Rohrmann S, Kanarek N, Nelson WG, Bradwin G, et al. Association between serum 25‐hydroxyvitamin D and serum sex steroid hormones among men in NHANES. Clin Endocrinol (Oxf). 2016;85(2):258-66.
30. Tak YJ, Lee JG, Kim YJ, Park NC, Kim SS, Lee S, et al. Serum 25-hydroxyvitamin D levels and testosterone deficiency in middle-aged Korean men: a cross-sectional study. Asian J Androl. 2015;17(2): 324.
31. Laczmanski L, Lwow F, Mossakowska M, Puzianowska-Kuznicka M, Szwed M, Kolackov K, et al. Association between vitamin D concentration and levels of sex hormones in an elderly Polish population with different genotypes of VDR polymorphisms (rs10735810, rs1544410, rs7975232, rs731236). Gene. 2015;559(1):73-6.
32. Tirabassi G, Sudano M, Salvio G, Cutini M, Muscogiuri G, Corona G, et al. Vitamin D and male sexual function: A transversal and longitudinal study. Int J Endocrinol. 2018;2018.
33. Wang N, Han B, Li Q, Chen Y, Chen Y, Xia F, et al. Vitamin D is associated with testosterone and hypogonadism in Chinese men: results from a cross-sectional SPECT-China study. Reprod Biol Endocrinol. 2015;13(1):1-7.
34. Lee DM, Tajar A, Pye SR, Boonen S, Vanderschueren D, Bouillon R, et al. Association of hypogonadism with vitamin D status: the European male ageing study. Eur J Endocrinol. 2012;166(1):77.
35. Jensen MB, Lawaetz JG, Andersson AM, Petersen JH, Nordkap L, Bang AK, et al. Vitamin D deficiency and low ionized calcium are linked with semen quality and sex steroid levels in infertile men. Hum Reprod. 2016;31(8):1875-85.
36. Ali SAA, Zainab ARAS, Hussain KAD. Impact of vitamin D on male Iraqi patients with infertility. Ann Trop Med Public Heal. 2020;23(20):232-40.
37. Seftel AD. Re: Association of hypogonadism with vitamin D status: The European male ageing study. J Urol. 2012;188(2):544.
38. Nimptsch K, Platz EA, Willett WC, Giovannucci E. Association between plasma 25-OH vitamin D and testosterone levels in men. Clin Endocrinol (Oxf). 2012;77(1):106-12.
39. Costa RR, Reis RI dos, Aguiar JF, Varanda WA. Luteinizing hormone (LH) acts through PKA and PKC to modulate T-type calcium currents and intracellular calcium transients in mice Leydig cells. Cell Calcium. 2011;49(3):191-9.
40. Sonnenberg J, Christakos S, Krey LC. 1,25-dihydr oxyvitamin D3 treatment results in increased choline acetyltransferase activity in specific brain nuclei. Endocrinology. 1986;118(4):1433-9.
41. Haussler MR, Jurutka PW, Mizwicki M, Norman AW. Vitamin D receptor (VDR)-mediated actions of 1α,25(OH) 2 vitamin D3: Genomic and non-genomic mechanisms. Best Pract Res Clin Endocrinol Metab. 2011;25(4):543-59.
42. Oury F, Sumara G, Sumara O, Ferron M, Chang H, Smith CE, et al. Endocrine regulation of male fertility by the skeleton. Cell. 2011; 144(5):796-809.
43. Zanatta L, Bouraïma-Lelong H, Delalande C, Silva FRMB, Carreau S. Regulation of aromatase expression by 1α,25(OH)2 vitamin D3 in rat testicular cells. Reprod Fertil Dev. 2011;23(5):725-35.
44. Dennis NA, Houghton LA, Jones GT, Van Rij AM, Morgan K, McLennan IS. The level of serum anti-müllerian hormone correlates with vitamin D status in men and women but not in boys. J Clin Endocrinol Metab. 2012;97(7):2450-5.
45. Parikh G, Varadinova M, Suwandhi P, Araki T, Rosenwaks Z, Poretsky L, et al. Vitamin D regulates steroidogenesis and insulin-like growth factor binding protein-1 (IGFBP-1) production in human ovarian cells. Horm Metab Res. 2010;42(10):754-7.
46. Clarke BL, Khosla S. Female reproductive system and bone. Arch Biochem Biophys. 2010;503(1):118-28.
47. Christensen A, Bentley GE, Cabrera R, Ortega HH, Perfito N, Wu TJ, et al. Hormonal regulation of female reproduction. Horm Metab Res. 2012;44(8):587-91.
48. McKenna MJ, Murray B. Vitamin D deficiency. Endocrinol Diabetes 2014;9781461486(3):293-304.
49. Sun W, Xie H, Ji J, Zhou X, Goltzman D, Miao D. Defective female reproductive function in 1,25(OH)2D-deficient mice results from indirect effect mediated by extracellular calcium and/or phosphorus. Am J Physiol Endocrinol Metab. 2010;299(6):E928-35.
50. Hodgins MB, Murad S. 1,25-Dihydroxycholecalciferol stimulates conversion of androstenedione into oestrone by human skin fibroblasts in culture. J Endocrinol. 1986;110(1):R1-4.
51. Aspell N, Lawlor B, O’Sullivan M. Is there a role for Vitamin D in supporting cognitive function as we age? Proc Nutr Soc. 2018; 77(2):124-34.
52. Abadia L, Gaskins AJ, Chiu YH, Williams PL, Keller M, Wright DL, et al. Serum 25-hydroxyvitamin D concentrations and treatment outcomes of women undergoing assisted reproduction. Am J Clin Nutr. 2016;104(3):729-35.
53. Aleyasin A, Hosseini MA, Mahdavi A, Safdarian L, Fallahi P, Mohajeri MR, et al. Predictive value of the level of vitamin D in follicular fluid on the outcome of assisted reproductive technology. Eur J Obstet Gynecol Reprod Biol. 2011;159(1):132-7.
54. Rudick B, Ingles S, Chung K, Stanczyk F, Paulson R, Bendikson K. Characterizing the influence of vitamin D levels on IVF outcomes. Hum Reprod. 2012;27(11):3321-7.
55. Rudick BJ, Ingles SA, Chung K, Stanczyk FZ, Paulson RJ, Bendikson KA. Influence of vitamin D levels on in vitro fertilization outcomes in donor-recipient cycles. Fertil Steril. 2014;101(2):447-52.
56. Yildizhan R, Kurdoglu M, Adali E, Kolusari A, Yildizhan B, Sahin HG, et al. Serum 25-hydroxyvitamin D concentrations in obese and non-obese women with polycystic ovary syndrome. Arch Gynecol Obstet. 2009;280(4):559-63.
57. Chang EM, Kim YS, Won HJ, Yoon TK, Lee WS. Association between sex steroids, ovarian reserve, and vitamin D levels in healthy nonobese women. J Clin Endocrinol Metab. 2014;99(7):2526-32.
58. Lorenzen M, Boisen IM, Mortensen LJ, Lanske B, Juul A, Blomberg Jensen M. Reproductive endocrinology of vitamin D. Mol Cell Endocrinol. 2017;453:103-12.
59. Merhi Z, Doswell A, Krebs K, Cipolla M. Vitamin D alters genes involved in follicular development and steroidogenesis in human cumulus granulosa cells. J Clin Endocrinol Metab. 2014;99(6):E1137-45.
60. Merhi ZO, Seifer DB, Weedon J, Adeyemi O, Holman S, Anastos K, et al. Circulating vitamin D correlates with serum antimüllerian hormone levels in late-reproductive-aged women: Women’s interagency HIV study. Fertil Steril. 2012;98(1):228-34.
61. Drakopoulos P, Van De Vijver A, Schutyser V, Milatovic S, Anckaert E, Schiettecatte J, et al. The effect of serum Vitamin D levels on ovarian reserve markers: A prospective cross-sectional study. Hum Reprod. 2017;32(1):208-14.
62. Neville G, Martyn F, Kilbane M, O’Riordan M, Wingfield M, McKenna M, et al. Vitamin D status and fertility outcomes during winter among couples undergoing in vitro fertilization/intracytoplasmic sperm injection. Int J Gynecol Obstet. 2016;135(2): 172-6.
63. Sertoglu E, Uyanik M, Kayadibi H. A biochemical view: Vitamin D levels do not affect in vitro fertilization outcomes following the transfer of euploid blastocysts. Am J Obstet Gynecol. 2015;212(3):411.
64. Paffoni A, Ferrari S, Viganò P, Pagliardini L, Papaleo E, Candiani M, et al. Vitamin D deficiency and infertility: Insights from in vitro fertilization cycles. J Clin Endocrinol Metab. 2014;99(11):E2372-6.
65. Hu KL, Gan K, Wang R, Li W, Wu Q, Zheng B, et al. Vitamin D supplementation prior to in vitro fertilisation in women with polycystic ovary syndrome: A protocol of a multicentre randomised, double-blind, placebo-controlled clinical trial. BMJ Open. 2020; 10(12):e041409.
66. Mnallah S, Berjeb KK, Khrouf M, Chtourou S, Elloumi H, Bahri O, et al. Impact of vitamin D deficiency on ICSI outcomes. JFIV Reprod Med Genet. 2017;5(2).
67. Gregerson KA. Prolactin: Structure, function, and regulation of secretion. Knobil Neill’s Physiol Reprod. 2006:1703-26.
68. Bole-Feysot C, Goffin V, Edery M, Binart N, Kelly PA. Prolactin (PRL) and its receptor: Actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice. Endocr Rev. 1998;19(3):225-68.
69. Horseman ND. Prolactin. Berlin: Springer Science & Business Media; 2012.
70. Bernichtein S, Touraine P, Goffin V. New concepts in prolactin biology. J Endocrinol. 2010;206(1):1-11.
71. Abed MN, Alassaf FA, Qazzaz ME, Alfahad M, Jasim MHM. Insights into the perspective correlation between vitamin D and regulation of hormones: Thyroid and Parathyroid Hormones. Clin Rev Bone Miner Metab. 2021;1-7.
72. Cabrera-Reyes EA, Limón-Morales O, Rivero-Segura NA, Camacho-Arroyo I, Cerbón M. Prolactin function and putative expression in the brain. Endocrine. 2017;57(2):199-213.
73. Phillipps HR, Yip SH, Grattan DR. Patterns of prolactin secretion. Mol Cell Endocrinol. 2020;502:110679.
74. Saki F, Sadeghian F, Kasaee SR, Koohpeyma F, Ranjbar Omrani GH. Effect of prolactin and estrogen on the serum level of 1,25-dihydroxy vitamin D and FGF23 in female rats. Arch Gynecol Obstet. 2020; 302(1):265-71.
75. Haug E, Pedersen JI, Gautvik KM. Effects of vitamin D3 metabolites on PRL and GH production in rat pituitary cells. J Steroid Biochem. 1982;17(3):65-79.
76. Tornquist K. Effect of 1,25-dihydroxyvitamin D3 on rat pituitary prolactin release. Acta Endocrinol (Copenh). 1987;116(4):459-64.
77. Törnquist K. 1, 25-Dihydroxycholecalciferol enhances both the bombesin-induced transient in intracellular free ca2+ and the bombesin-induced secretion of prolactin in GH4C1 pituitary cells. Endocrinology. 1991;128(4):2175-82.
78. Welt CK. Patient education: Absent or irregular periods (Beyond the Basics);2020.
79. Ali M, Mirza L. Morbid obesity due to prolactinoma and significant weight loss after dopamine agonist treatment. AACE Clin Case Reports. 2021;7(3):204-6.
80. Wark JD, Tashjian AH. Vitamin D stimulates prolactin synthesis by GH4C1 cells incubated in chemically defined medium. Endocrinology. 1982;111(5):1755-7.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 Unported License.
Copyright (c) 2021 Authors